Abstract
Diethyl-HIDA, a new hepatobiliary radiopharmaceutical labeled with99mTc, was used in the preoperative diagnosis of biliary atresia and in the postoperative evaluation of hepatic-porto-enterostomy function. The good results obtained in the four first cases suggest extensive use of the method, with the aim of a more precocious and more attendable diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harvey, E., Loberg, M. and Cooper, M.:99mTc HIDA: a new radiopharmaceutical for hepatobiliary imaging,J. Nucl. Med., 16: 533–539, 1975.
Kasai, M.: Treatment of biliary atresia with special reference to hepatic-portoenterostomy and its modifications,Progr. in Pediatr. Surg. 6: 5–52, 1974.
Kasai, M.: Il valore dell'agobiopsia del fegato e del CBA Score test nella diagnosi differenziale tra l'atresiadelle vie biliari e l'epatite neonatale. Presented at the X Symposius internazionale di Epatologia, Chianciano Terme, May 21, 1977.
Loberg, M., Cooper, M., Harvey, E. et al.: Development of new radiopharmaceuticals based on N substition of iminodiacetic acid,J. Nucl. Med., 17: 633–638, 1976.
Wistow, B.W., Subramanian, G., Van Heertum, R.L. et al.: An evaluation of99mTc labeled hepatobiliary agents,J. Nucl. Med., 18: 455–461, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Georgacopulo, P., Bagni, B., Feggi, L.M. et al. A radiopharmaceutical in the diagnosis of congenital biliary atresia. The Japanese Journal of Surgery 9, 55–62 (1979). https://doi.org/10.1007/BF02468716
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02468716